GPT and neoplasm: Therefore, we speculate that the better prognosis of patients with a pre-treatment AST/ALT ratio exceeding 1.7 after receiving iRT may be due to their lower ALT levels, which reduce glutamine metabolism, promote T cell proliferation and activation, reverse the inhibitory immune microenvironment, and enhance the anti-tumor immune response.